Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design

Current Opinion in Virology

Volumn 11, Issue , 2015, Pages 63-69

  Crispin, Max ^a   Doores, Katie J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CARBOHYDRATE; EPITOPE; GLYCAN; GLYCOPROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VACCINE; MEMBRANE PROTEIN; POLYSACCHARIDE; VIRAL PROTEIN;

ANTIBODY ISOLATION; ANTIVIRAL ACTIVITY; ARTICLE; DRUG DESIGN; EBOLA VIRUS; GLYCOBIOLOGY; GOLGI COMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IC50; INDEL MUTATION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SECRETORY PATHWAY; SOMATIC HYPERMUTATION; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS SPIKE; VIRUS STRAIN; GLYCOSYLATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; VIRUS;

ANTIBODIES, VIRAL; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MEMBRANE GLYCOPROTEINS; POLYSACCHARIDES; VIRAL PROTEINS; VIRAL VACCINES; VIRUSES;

EID: 84924787042     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.02.002     Document Type: Review

References (73)

1. R.D. Astronomo, and D.R. Burton Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov 9 2010 308 324
2. R. Kornfeld, and S. Kornfeld Assembly of asparagine-linked oligosaccharides Annu Rev Biochem 54 1985 631 664
3. C.N. Scanlan, J. Offer, N. Zitzmann, and R.A. Dwek Exploiting the defensive sugars of HIV-1 for drug and vaccine design Nature 446 2007 1038 1045
4. P.M. Rudd, and R.A. Dwek Glycosylation: heterogeneity and the 3D structure of proteins Crit Rev Biochem Mol Biol 32 1997 1 100
5. M. Crispin, D.J. Harvey, D. Bitto, C. Bonomelli, M. Edgeworth, J.H. Scrivens, J.T. Huiskonen, and T.A. Bowden Structural plasticity of the semliki forest virus glycome upon interspecies transmission J Proteome Res 13 2014 1702 1712
6. W. Dejnirattisai, A.I. Webb, V. Chan, A. Jumnainsong, A. Davidson, J. Mongkolsapaya, and G. Screaton Lectin switching during dengue virus infection J Infect Dis 203 2011 1775 1783
7. K. Hacker, L. White, and A.M. de Silva N-linked glycans on dengue viruses grown in mammalian and insect cells J Gen Virol 90 Pt 9 2009 2097 2106
8. S.J. Neil, A. McKnight, K. Gustafsson, and R.A. Weiss HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation Blood 105 2005 4693 4699
9. G. Vieyres, X. Thomas, V. Descamps, G. Duverlie, A.H. Patel, and J. Dubuisson Characterization of the envelope glycoproteins associated with infectious hepatitis C virus J Virol 84 2010 10159 10168
10. P.Y. Lozach, A. Kuhbacher, R. Meier, R. Mancini, D. Bitto, M. Bouloy, and A. Helenius DC-SIGN as a receptor for phleboviruses Cell Host Microbe 10 2011 75 88
11. M. Crispin, D.J. Harvey, D. Bitto, S. Halldorsson, C. Bonomelli, M. Edgeworth, J.H. Scrivens, J.T. Huiskonen, and T.A. Bowden Uukuniemi phlebovirus assembly and secretion leave a functional imprint on the virion glycome J Virol 88 2014 10244 10251
12. J.E. Lee, M.L. Fusco, A.J. Hessell, W.B. Oswald, D.R. Burton, and E.O. Saphire Structure of the ebola virus glycoprotein bound to an antibody from a human survivor Nature 454 2008 177 182
13. A.S. Powlesland, T. Fisch, M.E. Taylor, D.F. Smith, B. Tissot, A. Dell, S. Pohlmann, and K. Drickamer A novel mechanism for LSECtin binding to ebola virus surface glycoprotein through truncated glycans J Biol Chem 283 2008 593 602
14. G. Ritchie, D.J. Harvey, U. Stroeher, F. Feldmann, H. Feldmann, V. Wahl-Jensen, L. Royle, R.A. Dwek, and P.M. Rudd Identification of N-glycans from ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry Rapid Commun Mass Spectrom 24 2010 571 585
15. T.A. Bowden, M. Crispin, D.J. Harvey, A.R. Aricescu, J.M. Grimes, E.Y. Jones, and D.I. Stuart Crystal structure and carbohydrate analysis of nipah virus attachment glycoprotein: a template for antiviral and vaccine design J Virol 82 2008 11628 11636
16. T.A. Bowden, M. Crispin, D.J. Harvey, E.Y. Jones, and D.I. Stuart Dimeric architecture of the hendra virus attachment glycoprotein: evidence for a conserved mode of assembly J Virol 84 2010 6208 6217
17. T.A. Bowden, M. Crispin, S.C. Graham, D.J. Harvey, J.M. Grimes, E.Y. Jones, and D.I. Stuart Unusual molecular architecture of the machupo virus attachment glycoprotein J Virol 83 2009 8259 8265
18. B. Korber, B. Gaschen, K. Yusim, R. Thakallapally, C. Kesmir, and V. Detours Evolutionary and immunological implications of contemporary HIV-1 variation Br Med Bull 58 2001 19 42
19. C. Bonomelli, K.J. Doores, D.C. Dunlop, V. Thaney, R.A. Dwek, D.R. Burton, M. Crispin, and C.N. Scanlan The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade PLoS ONE 6 2011 e23521
20. K.J. Doores, C. Bonomelli, D.J. Harvey, S. Vasiljevic, R.A. Dwek, D.R. Burton, M. Crispin, and C.N. Scanlan Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens Proc Natl Acad Sci U S A 107 2010 13800 13805
21. C.K. Leonard, M.W. Spellman, L. Riddle, R.J. Harris, J.N. Thomas, and T.J. Gregory Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells J Biol Chem 265 1990 10373 10382
22. X. Zhu, C. Borchers, R.J. Bienstock, and K.B. Tomer Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells Biochemistry 39 2000 11194 11204
23. E.P. Go, H.X. Liao, S.M. Alam, D. Hua, B.F. Haynes, and H. Desaire Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins J Proteome Res 12 2013 1223 1234
24. K.B. Alexandre, E.S. Gray, B.E. Lambson, P.L. Moore, I.A. Choge, K. Mlisana, S.S. Karim, J. McMahon, B. O'Keefe, R. Chikwamba, and L. Morris Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, griffithsin, cyanovirin-N and scytovirin Virology 402 2010 187 196
25. J.P. Julien, A. Cupo, D. Sok, R.L. Stanfield, D. Lyumkis, M.C. Deller, P.J. Klasse, D.R. Burton, R.W. Sanders, J.P. Moore, and A.B. Ward Crystal structure of a soluble cleaved HIV-1 envelope trimer Science 342 2013 1477 1483
26. D. Lyumkis, J.P. Julien, N. de Val, A. Cupo, C.S. Potter, P.J. Klasse, D.R. Burton, R.W. Sanders, J.P. Moore, B. Carragher, and I.A. Wilson Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer Science 342 2013 1484 1490
27. M. Pancera, T. Zhou, A. Druz, I.S. Georgiev, C. Soto, J. Gorman, J. Huang, P. Acharya, G.Y. Chuang, G. Ofek, and G.B. Stewart-Jones Structure and immune recognition of trimeric pre-fusion HIV-1 Env Nature 514 2014 455 461
28. D. Eggink, M. Melchers, M. Wuhrer, T. van Montfort, A.K. Dey, B.A. Naaijkens, K.B. David, V. Le Douce, A.M. Deelder, K. Kang, and W.C. Olson Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function Virology 401 2010 236 247
29. P.D. Kwong, J.R. Mascola, and G.J. Nabel Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning Nat Rev Immunol 13 2013 693 701
30. L.M. Walker, M. Huber, K.J. Doores, E. Falkowska, R. Pejchal, J.P. Julien, S.K. Wang, A. Ramos, P.Y. Chan-Hui, M. Moyle, and J.L. Mitcham Broad neutralization coverage of HIV by multiple highly potent antibodies Nature 477 2011 466 470
31. X. Wu, Z.Y. Yang, Y. Li, C.M. Hogerkorp, W.R. Schief, M.S. Seaman, T. Zhou, S.D. Schmidt, L. Wu, L. Xu, and N.S. Longo Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 Science 329 2010 856 861
32. J.F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T.Y. Oliveira, J. Pietzsch, D. Fenyo, A. Abadir, K. Velinzon, and A. Hurley Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding Science 333 2011 1633 1637
33. L.M. Walker, S.K. Phogat, P.Y. Chan-Hui, D. Wagner, P. Phung, J.L. Goss, T. Wrin, M.D. Simek, S. Fling, J.L. Mitcham, and J.K. Lehrman Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target Science 326 2009 285 289
34. H.X. Liao, R. Lynch, T. Zhou, F. Gao, S.M. Alam, S.D. Boyd, A.Z. Fire, K.M. Roskin, C.A. Schramm, Z. Zhang, and J. Zhu Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Nature 496 2013 469 476
35. J. Huang, G. Ofek, L. Laub, M.K. Louder, N.A. Doria-Rose, N.S. Longo, H. Imamichi, R.T. Bailer, B. Chakrabarti, S.K. Sharma, and S.M. Alam Broad and potent neutralization of HIV-1 by a gp41-specific human antibody Nature 491 2012 406 412
36. B. Moldt, E.G. Rakasz, N. Schultz, P.Y. Chan-Hui, K. Swiderek, K.L. Weisgrau, S.M. Piaskowski, Z. Bergman, D.I. Watkins, P. Poignard, and D.R. Burton Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo Proc Natl Acad Sci U S A 109 2012 18921 18925
37. M. Shingai, O.K. Donau, R.J. Plishka, A. Buckler-White, J.R. Mascola, G.J. Nabel, M.C. Nason, D. Montefiori, B. Moldt, P. Poignard, and R. Diskin Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques J Exp Med 211 2014 2061 2074
38. D.R. Burton, R. Ahmed, D.H. Barouch, S.T. Butera, S. Crotty, A. Godzik, D.E. Kaufmann, M.J. McElrath, M.C. Nussenzweig, B. Pulendran, and C.N. Scanlan A blueprint for HIV vaccine discovery Cell Host Microbe 12 2012 396 407
39. H. Mouquet, L. Scharf, Z. Euler, Y. Liu, C. Eden, J.F. Scheid, A. Halper-Stromberg, P.N. Gnanapragasam, D.I. Spencer, M.S. Seaman, and H. Schuitemaker Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies Proc Natl Acad Sci U S A 109 2012 E3268 E3277
40. C.N. Scanlan, R. Pantophlet, M.R. Wormald, E. Ollmann Saphire, R. Stanfield, I.A. Wilson, H. Katinger, R.A. Dwek, P.M. Rudd, and D.R. Burton The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1→2 mannose residues on the outer face of gp120 J Virol 76 2002 7306 7321
41. M. Bonsignori, K.K. Hwang, X. Chen, C.Y. Tsao, L. Morris, E. Gray, D.J. Marshall, J.A. Crump, S.H. Kapiga, N.E. Sam, and F. Sinangil Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors J Virol 85 2011 9998 10009
42. E. Falkowska, K.M. Le, A. Ramos, K.J. Doores, J.H. Lee, C. Blattner, A. Ramirez, R. Derking, M.J. van Gils, C.H. Liang, and R. McBride Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers Immunity 40 2014 657 668
43. J. Huang, B.H. Kang, M. Pancera, J.H. Lee, T. Tong, Y. Feng, I.S. Georgiev, G.Y. Chuang, A. Druz, N.A. Doria-Rose, and L. Laub Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface Nature 515 2014 138 142
44. D.A. Calarese, C.N. Scanlan, M.B. Zwick, S. Deechongkit, Y. Mimura, R. Kunert, P. Zhu, M.R. Wormald, R.L. Stanfield, K.H. Roux, and J.W. Kelly Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science 300 2003 2065 2071
45. C.D. Murin, J.P. Julien, D. Sok, R.L. Stanfield, R. Khayat, A. Cupo, J.P. Moore, D.R. Burton, I.A. Wilson, and A.B. Ward Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy J Virol 88 2014 10177 10188
46. L. Kong, J.H. Lee, K.J. Doores, C.D. Murin, J.P. Julien, R. McBride, Y. Liu, A. Marozsan, A. Cupo, P.J. Klasse, and S. Hoffenberg Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 Nat Struct Mol Biol 20 2013 796 803
47. R. Pejchal, K.J. Doores, L.M. Walker, R. Khayat, P.S. Huang, S.K. Wang, R.L. Stanfield, J.P. Julien, A. Ramos, M. Crispin, and R. Depetris A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield Science 334 2011 1097 1103
48. J.P. Julien, J.H. Lee, A. Cupo, C.D. Murin, R. Derking, S. Hoffenberg, M.J. Caulfield, C.R. King, A.J. Marozsan, P.J. Klasse, and R.W. Sanders Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9 Proc Natl Acad Sci U S A 110 2013 4351 4356
49. M. Pancera, S. Shahzad-Ul-Hussan, N.A. Doria-Rose, J.S. McLellan, R.T. Bailer, K. Dai, S. Loesgen, M.K. Louder, R.P. Staupe, Y. Yang, and B. Zhang Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16 Nat Struct Mol Biol 20 2013 804 813
50. J.S. McLellan, M. Pancera, C. Carrico, J. Gorman, J.P. Julien, R. Khayat, R. Louder, R. Pejchal, M. Sastry, K. Dai, and S. O'Dell Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 Nature 480 2011 336 343
51. O. Haji-Ghassemi, S. Muller-Loennies, R. Saldova, M. Muniyappa, L. Brade, P.M. Rudd, D.J. Harvey, P. Kosma, H. Brade, and S.V. Evans Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan J Biol Chem 289 2014 16644 16661
52. C.L. Brooks, A. Schietinger, S.N. Borisova, P. Kufer, M. Okon, T. Hirama, C.R. Mackenzie, L.X. Wang, H. Schreiber, and S.V. Evans Antibody recognition of a unique tumor-specific glycopeptide antigen Proc Natl Acad Sci U S A 107 2010 10056 10061
53. M. Crispin, and T.A. Bowden Antibodies expose multiple weaknesses in the glycan shield of HIV Nat Struct Mol Biol 20 2013 771 772
54. D.C. Dunlop, C. Bonomelli, F. Mansab, S. Vasiljevic, K.J. Doores, M.R. Wormald, A.S. Palma, T. Feizi, D.J. Harvey, R.A. Dwek, and M. Crispin Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans Glycobiology 20 2010 812 823
55. D.C. Dunlop, A. Ulrich, B.J. Appelmelk, D.R. Burton, R.A. Dwek, N. Zitzmann, and C.N. Scanlan Antigenic mimicry of the HIV envelope by AIDS-associated pathogens AIDS 22 2008 2214 2217
56. C. Agrawal-Gamse, R.J. Luallen, B. Liu, H. Fu, F.H. Lee, Y. Geng, and R.W. Doms Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans J Virol 85 2011 470 480
57. L.X. Wang Synthetic carbohydrate antigens for HIV vaccine design Curr Opin Chem Biol 17 2013 997 1005
58. K.J. Doores, Z. Fulton, M. Huber, I.A. Wilson, and D.R. Burton Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged J Virol 84 2010 10690 10699
59. M.N. Amin, J.S. McLellan, W. Huang, J. Orwenyo, D.R. Burton, W.C. Koff, P.D. Kwong, and L.X. Wang Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies Nat Chem Biol 9 2013 521 526
60. F. Garces, D. Sok, L. Kong, R. McBride, H.J. Kim, K.F. Saye-Francisco, J.P. Julien, Y. Hua, A. Cupo, J.P. Moore, and J.C. Paulson Structural evolution of glycan recognition by a family of potent HIV antibodies Cell 159 2014 69 79
61. K.J. Doores, L. Kong, S.A. Krumm, K.M. Le, D. Sok, U. Laserson, F. Garces, P. Poignard, I.A. Wilson, and D.R. Burton Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope J Virol 89 2015 1105 1118
62. D. Sok, U. Laserson, J. Laserson, Y. Liu, F. Vigneault, J.P. Julien, B. Briney, A. Ramos, K.F. Saye, K. Le, and A. Mahan The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies PLoS Pathog 9 2013 e1003754
63. T.B. Kepler, H.X. Liao, S.M. Alam, R. Bhaskarabhatla, R. Zhang, C. Yandava, S. Stewart, K. Anasti, G. Kelsoe, R. Parks, and K.E. Lloyd Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies Cell Host Microbe 16 2014 304 313
64. N.A. Doria-Rose, C.A. Schramm, J. Gorman, P.L. Moore, J.N. Bhiman, B.J. DeKosky, M.J. Ernandes, I.S. Georgiev, H.J. Kim, M. Pancera, and R.P. Staupe Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies Nature 509 2014 55 62
65. P.L. Moore, E.S. Gray, C.K. Wibmer, J.N. Bhiman, M. Nonyane, D.J. Sheward, T. Hermanus, S. Bajimaya, N.L. Tumba, M.R. Abrahams, and B.E. Lambson Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape Nat Med 18 2012 1688 1692
66. Y. Iba, Y. Fujii, N. Ohshima, T. Sumida, R. Kubota-Koketsu, M. Ikeda, M. Wakiyama, M. Shirouzu, J. Okada, Y. Okuno, and Y. Kurosawa Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses J Virol 88 2014 7130 7144
67. L. Kong, E. Giang, T. Nieusma, R.U. Kadam, K.E. Cogburn, Y. Hua, X. Dai, R.L. Stanfield, D.R. Burton, A.B. Ward, and I.A. Wilson Hepatitis C virus E2 envelope glycoprotein core structure Science 342 2013 1090 1094
68. L.G. Barrientos, B.R. O'Keefe, M. Bray, A. Sanchez, A.M. Gronenborn, and M.R. Boyd Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of ebola virus Antiviral Res 58 2003 47 56
69. A.R. Garrison, B.G. Giomarelli, C.M. Lear-Rooney, C.J. Saucedo, S. Yellayi, L.R. Krumpe, M. Rose, J. Paragas, M. Bray, G.G. Olinger Jr., and J.B. McMahon The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against zaire ebola virus Antiviral Res 112C 2014 1 7
70. A. Kachko, S. Loesgen, S. Shahzad-Ul-Hussan, W. Tan, I. Zubkova, K. Takeda, F. Wells, S. Rubin, C.A. Bewley, and M.E. Major Inhibition of hepatitis C virus by the cyanobacterial protein microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA Mol Pharm 10 2013 4590 4602
71. M.M. Alen, S.J. Kaptein, T. De Burghgraeve, J. Balzarini, J. Neyts, and D. Schols Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection Virology 387 2009 67 75
72. C.M. Arthur, R.D. Cummings, and S.R. Stowell Using glycan microarrays to understand immunity Curr Opin Chem Biol 18 2014 55 61
73. T. Tiller, E. Meffre, S. Yurasov, M. Tsuiji, M.C. Nussenzweig, and H. Wardemann Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning J Immunol Methods 329 2008 112 124